Biotech10 months ago
Novo Nordisk Signs Agreements for Almost €1 Billion with Laboratories Supported by Flagship
Novo Nordisk has entered independent research collaboration agreements with Omega Therapeutics and Cellarity to develop innovative therapeutic approaches for cardiometabolic diseases, with each company potentially receiving...